Syndax Pharmaceuticals
SNDX
SNDX
99 hedge funds and large institutions have $493M invested in Syndax Pharmaceuticals in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 28 increasing their positions, 36 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
10% less call options, than puts
Call options by funds: $1.12M | Put options by funds: $1.24M
1.63% less ownership
Funds ownership: 90.44% → 88.81% (-1.6%)
22% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 36
Holders
99
Holding in Top 10
2
Calls
$1.12M
Puts
$1.24M
Top Buyers
| 1 | +$19.8M | |
| 2 | +$9.59M | |
| 3 | +$9.53M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$4.82M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$4.28M |
Top Sellers
| 1 | -$7.07M | |
| 2 | -$6.29M | |
| 3 | -$4.8M | |
| 4 |
BlackRock
New York
|
-$3.92M |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$3.8M |